Synthesis, structure-activity relationship and in vitro pharmacodynamics of A-ring modified caged xanthones in a preclinical model of inflammatory breast cancer.

MLA

Chantarasriwong, Oraphin, et al. “Synthesis, Structure-Activity Relationship and in Vitro Pharmacodynamics of A-Ring Modified Caged Xanthones in a Preclinical Model of Inflammatory Breast Cancer.” European Journal of Medicinal Chemistry, vol. 168, Apr. 2019, pp. 405–13. EBSCOhost, https://doi.org/10.1016/j.ejmech.2019.02.047.

APA

Chantarasriwong, O., Milcarek, A. T., Morales, T. H., Settle, A. L., Rezende, C. O., Jr, Althufairi, B. D., Theodoraki, M. A., Alpaugh, M. L., & Theodorakis, E. A. (2019). Synthesis, structure-activity relationship and in vitro pharmacodynamics of A-ring modified caged xanthones in a preclinical model of inflammatory breast cancer. European Journal of Medicinal Chemistry, 168, 405–413. https://doi.org/10.1016/j.ejmech.2019.02.047

Chicago

Chantarasriwong, Oraphin, Andrew T Milcarek, Theodore Habarth Morales, Aspen L Settle, Celso O Rezende Jr, Bashayer D Althufairi, Maria A Theodoraki, Mary L Alpaugh, and Emmanuel A Theodorakis. 2019. “Synthesis, Structure-Activity Relationship and in Vitro Pharmacodynamics of A-Ring Modified Caged Xanthones in a Preclinical Model of Inflammatory Breast Cancer.” European Journal of Medicinal Chemistry 168 (April): 405–13. doi:10.1016/j.ejmech.2019.02.047.